Search results for "VIRUS DISEASE"

showing 10 items of 1907 documents

Direct-acting antiviral-based therapy for chronic hepatitis C virus in HIV-infected patients

2015

The aim of this review was to detail the current therapies and treatments for chronic hepatitis C virus in coinfected patients, focusing on HCV antiviral agents currently used in practice today or scheduled to enter the open market soon. Several direct-acting antiviral (DAA) combinations show high sustained virologic response (SVR) rates in HIV/HCV-coinfected patients, which are often close to those observed in HCV-monoinfected patients. Most recommendations regarding treatment stem from trials with coinfected patients. However, data are lacking for some aspects of HCV-treatment in coinfection, so extrapolations must be made from data obtained predominately from monoinfected patients. HIV/H…

medicine.medical_specialtyHepatitis C virusImmunologyPopulationHuman immunodeficiency virus (HIV)HIV Infectionsmedicine.disease_causeAntiviral AgentsVirusLiver diseaseChronic hepatitisVirologyInternal medicinemedicineHumansHiv infected patientsDrug Interactionseducationeducation.field_of_studyOncology (nursing)business.industryvirus diseasesHematologyHepatitis C Chronicmedicine.diseasedigestive system diseasesTreatment OutcomeInfectious DiseasesOncologyImmunologyCoinfectionDrug Therapy CombinationbusinessCurrent Opinion in HIV and AIDS
researchProduct

Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort

2017

BACKGROUND AND AIMS: Few data exist on changes to substance use patterns before and after hepatitis C virus (HCV) treatment. We used longitudinal data of HIV-HCV co-infected individuals to examine whether receiving pegylated interferon (Peg-IFN)-based therapy irrespective of HCV clearance could modify tobacco, cannabis and alcohol use. DESIGN: A prospective cohort of HIV-HCV co-infected individuals was enrolled from 2006. Participants' clinical data were retrieved from medical records and socio-demographic and behavioural characteristics were collected by yearly self-administered questionnaires. SETTING: Data were collected across 17 hospitals in France. PARTICIPANTS: All HIV-HCV co-infecte…

medicine.medical_specialtyHepatitis C virusMedicine (miscellaneous)Binge drinkingmedicine.disease_causeUnit of alcohol03 medical and health sciences0302 clinical medicinePegylated interferonInternal medicinemedicine030212 general & internal medicineProspective cohort studybiologybusiness.industryvirus diseasesHepatitis Cmedicine.diseasebiology.organism_classificationVirologydigestive system diseases3. Good healthPsychiatry and Mental healthCohort030211 gastroenterology & hepatologyCannabisbusinessmedicine.drugAddiction
researchProduct

Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis C

2012

Summary.  Under-enrolment of women to randomized clinical trials, including chronic hepatitis C, has long been recognized. The aim of this study was to identify factors predictive of sustained virological response (SVR) to PEG IFN/Ribavirin antiviral therapy in relation to gender and reproductive status of female patients involved. Seven hundred and forty-six treatment-naive patients (431 men, 315 women) treated with Peg-IFNα-2a (180 μg/week) or Peg-IFNα-2b (1.5 μg/kg/week) plus ribavirin (800–1400  mg/day) for 24 or 48 weeks were studied between 2006 and 2010. Differences in SVR rate, overall and by gender were assessed after adjustment and propensity score matching. SVR was obtained in 44…

medicine.medical_specialtyHepatitis C virusPopulationmacromolecular substancesmedicine.disease_causeGastroenterologylaw.inventionchemistry.chemical_compoundRandomized controlled triallawVirologyInternal medicineMedicineeducationeducation.field_of_studyHepatologybusiness.industryRibavirintechnology industry and agriculturevirus diseasesmedicine.diseasedigestive system diseasesMenopauseInfectious DiseasesEndocrinologychemistryPropensity score matchingSteatosisMetabolic syndromebusinessJournal of Viral Hepatitis
researchProduct

Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin

2012

Summary.  It is unclear whether the current threshold for ‘high’ hepatitis C virus (HCV) RNA level (800 000 IU/mL) is optimal for predicting sustained virological response (SVR). We retrospectively analysed pretreatment HCV RNA levels and SVR rates in 1529 mono-infected and 176 HIV–HCV co-infected patients treated with peginterferon alfa-2a (40 kD) plus ribavirin. We improved the threshold for differentiating low and high viral load by fitting semiparametric generalized additive logistic regression models to the data and constructing receiver operating characteristics curves. Among HCV genotype 1 mono-infected patients, the difference in SVR rates between those with low and high baseline HC…

medicine.medical_specialtyHepatologyReceiver operating characteristicbusiness.industryRibavirinHepatitis C virusvirus diseasesHepatitis Cmedicine.diseaseLogistic regressionmedicine.disease_causeGastroenterologydigestive system diseaseschemistry.chemical_compoundInfectious DiseaseschemistryVirologyInternal medicineGenotypeImmunologymedicinebusinessViral loadPeginterferon alfa-2amedicine.drugJournal of Viral Hepatitis
researchProduct

Treatment of acute hepatitis C in human immunodeficiency virus-infected patients: The HEPAIG study

2010

Acute hepatitis C continues to be a concern in men who have sex with men (MSM), and its optimal management has yet to be established. In this study, the clinical, biological, and therapeutic data of 53 human immunodeficiency virus (HIV)-infected MSM included in a multicenter prospective study on acute hepatitis C in 2006-2007 were retrospectively collected and analyzed. The mean hepatitis C virus (HCV) viral load at diagnosis was 5.8 ± 1.1 log10 IU/mL (genotype 4, n = 28; genotype 1, n = 14, genotype 3, n = 7). The cumulative rates of spontaneous HCV clearance were 11.0% and 16.5% 3 and 6 months after diagnosis, respectively. Forty patients were treated, 38 of whom received pegylated interf…

medicine.medical_specialtyHepatologybusiness.industryRibavirinHepatitis C virusvirus diseasesHepatitis CHepatologymedicine.diseasemedicine.disease_causeGastroenterologydigestive system diseasesMen who have sex with menchemistry.chemical_compoundchemistryPegylated interferonInternal medicineImmunologymedicineProspective cohort studybusinessViral loadmedicine.drugHepatology
researchProduct

Studies on a measles virus variant inducing persistent infections in cultured cells

1976

Attempts were made to characterized by a plaque assay two variants of the Edmonston strain of measles virus and to obtain plaque purified virus populations. The UP non-cytocidal variant, in all the examined cell systems, mainly produced small but also large plaques; the DP cytocidal variant always large plaques. Three clones, UP-SP4, UP-LP4 and DP-LP4, were derived by plaque purfication respectively of the UP small plaque, UP large plaque and DP large plaque forming particles. The virus populations of the clones could be distinguished by some other biological and physical characters: cytopathic effect in roller tube cultures, growth potential in HeLa cells, thermal stability at 45 degrees C…

medicine.medical_specialtyHot TemperaturevirusesViral Plaque AssayVirus Replicationcomplex mixturesVirusCell LineMeasles virusMedical microbiologyVirologyViral InterferencemedicineAnimalsCytopathic effectVirus quantificationStrain (chemistry)biologyDefective VirusesGenetic Variationvirus diseasesHaplorhiniGeneral MedicineIsolation (microbiology)biology.organism_classificationVirologyMeasles virusHeLa CellsArchives of Virology
researchProduct

Illness perceptions of COVID-19 in Europe: Predictors, impacts and temporal evolution

2021

Objective: Illness perceptions (IP) are important predictors of emotional and behavioral responses in many diseases. The current study aims to investigate the COVID-19-related IP throughout Europe. The specific goals are to understand the temporal development, identify predictors (within demographics and contact with COVID-19) and examine the impacts of IP on perceived stress and preventive behaviors. Methods: This was a time-series-cross-section study of 7, 032 participants from 16 European countries using multilevel modeling from April to June 2020. IP were measured with the Brief Illness Perception Questionnaire. Temporal patterns were observed considering the date of participation and t…

medicine.medical_specialtyIllness representationsCoronavirus disease 2019 (COVID-19)Demographicsmedia_common.quotation_subjectlcsh:BF1-990Common sense modelContext (language use)PercepciónStressMedical and Health SciencespandemiatDevelopmental psychology[SHS]Humanities and Social SciencesIllness perceptions03 medical and health sciencesstress0302 clinical medicineitsesäätely (psykologia)Efectos psicológicosPerceptionvertaileva tutkimusPandemicEpidemiologyEpidemiamedicinePsychology030212 general & internal medicineGeneral Psychologymedia_commonOriginal Researchillness perceptions030505 public healthcommon sense modelMultilevel modelCOVID-19stressisairauskäsitykset3. Good healthCoronavirusillness representationslcsh:PsychologyterveyskäyttäytyminenClinical Medicine0305 other medical sciencePsychologyIllness perceptions
researchProduct

Alarming increased rate of smoking and associated lifestyle behaviours in patients with chronic cardiac diseases during COVID-19 pandemic related loc…

2021

Background COVID-19 outbreak and lockdown is a situation associating social and physical isolation, limited care access, psychological stress, and potential adoption of unhealthy lifestyle behaviours such as smoking. In a cohort of outpatients with chronic cardiac diseases, including congestive heart failure (CHF) and chronic coronary syndromes (CCS), we aimed to evaluate the impact of Covid-19 outbreak on tobacco consumption. Patients and methods During the 6th week of lockdown (which had started on March, 17th), 150 randomly selected CHF patients (from the Dijon HF-Clinic) and 250 CCS patients from the RICO survey were invited to answer an anonymous questionnaire. The 20-min lasting phone…

medicine.medical_specialtyIsolation (health care)Coronavirus disease 2019 (COVID-19)business.industryOutbreakDisease030204 cardiovascular system & hematologymedicine.diseaseNicotine03 medical and health sciences0302 clinical medicine417Heart failureEmergency medicinePandemicCohortmedicine030212 general & internal medicineCardiology and Cardiovascular Medicinebusinessmedicine.drugArchives of Cardiovascular Diseases Supplements
researchProduct

Persistent endotheliopathy in the pathogenesis of long COVID syndrome

2021

Background Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. However, autopsy studies have highlighted the key roles played by pulmonary endotheliopathy and microvascular immunothrombosis in acute COVID-19. Objectives To assess whether endothelial cell activation may be sustained in convalescent COVID-19 patients and contribute to long COVID pathogenesis. Patients and Methods Fifty patients were reviewed at a median of 68 days following SARS-CoV-2 infection. In addition to clinical workup, acute phase markers, …

medicine.medical_specialtyLong COVIDCoronavirus disease 2019 (COVID-19)business.industryBrief ReportSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Acute-phase proteinAutopsyHematologyconvalescent COVID‐19GastroenterologyEndothelial stem cellPathogenesisThrombinInternal medicinemedicineBrief ReportsbusinessEndothelial cell (EC) activationmedicine.drugDECREASED EXERCISE TOLERANCEJournal of Thrombosis and Haemostasis
researchProduct

The Management of Dental Practices in the Post-COVID 19 Era: An Economic and Operational Perspective

2020

Background: In order to protect dental teams and their patients during the COVID-19 pandemic, dentists have had to adopt several measures (operating and post-operating procedures) which may increase the total treatment time and costs relating to individual protective measures. This paper will propose a thorough analysis of operating dentistry procedures, comparing the economic performance of the activity in a dental surgery before and after the adoption of these protective measures, which are required to contain the risk of SARS-COV-2 infections. Methods: The economic analysis is articulated in three approaches. Firstly, it assesses a reduction in markup by maintaining current charges (A)

medicine.medical_specialtyMarkup language010504 meteorology & atmospheric sciencesCoronavirus disease 2019 (COVID-19)Health Toxicology and Mutagenesislcsh:Medicine01 natural sciencesArticle03 medical and health sciences0302 clinical medicineOrder (exchange)medicineEconomic analysisHumansOperations managementEconomic impact analysisPandemicsEconomic consequences0105 earth and related environmental sciencesInfection ControldentistrySARS-CoV-2Perspective (graphical)lcsh:REconomics DentalPublic Health Environmental and Occupational HealthCOVID-19030206 dentistryeconomicsDental surgeryBusinessmanagement
researchProduct